In a mouse model of COPD induced by LPS injection and cigarette smoke inhalation, sunitinib, a specific tyrosine kinase inhibitor, has been shown to downregulate the expression of VEGF, VEGFR1, and VEGFR2. Here, FLT1 is linked to chronic obstructive pulmonary disease.